http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101769320-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-035 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101769320-B1 |
| titleOfInvention | Monoclonal antibody 108-B6 specific to PGRMC1 expressed on the surface of human embryonic stem cells and various cancer cells |
| abstract | The present invention relates to a monoclonal antibody 108-B6 recognizing PGRMC1 on the surface of human embryonic stem cells and cancer cells. More specifically, it relates to human embryonic stem cells and the carboxyl-terminal region of PGRMC1 expressed on the cancer cell surface A hybridoma producing the monoclonal antibody 108-B6 and the monoclonal antibody 108-B6, the composition for removing undifferentiated human embryonic stem cell comprising the monoclonal antibody 108-B6, and the monoclonal antibody 108-B6 A black kit is provided. Also provided is a method of providing information for cancer diagnosis, comprising detecting PGRMC1 protein using monoclonal antibody 108-B6 in a sample, and a method comprising providing monoclonal antibody 108-B6 that specifically binds to PGRMC1 protein A cancer diagnosis kit is provided. Specifically, the cancer is characterized by brain cancer, neuroblastoma, lung cancer, liver cancer, or embryonal cancer. |
| priorityDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 412.